Recently, Zhuhai United LaboratoriesCo.,Ltd(Zhongshan branch) declare the diabetes drug recombinant human insulin gene engineering series product research and development and industrialization "project won Zhuhai science and technology progress award " issued byZhuhai municipal people's government.This is for the project following won the first prize in science and technology progress prize of Zhongshan city, Guangdong province scientific and technological progress second prize, TUL get another major awards and honors.

TUL’s recombinant human insulin with pichia expression technique, its efficacy and safety similar as imported products, has the good market competitiveness. “USLIN ?" series of products since 2010, born for the majority of patients who suffer from diabetes at the same time, excellent quality, curative effect is distinct features of the product also received high recognition of the market.At present, TUL group plan to extend production scale in new workshop, in order to improve the production capacity of series products of recombinant human insulin, to satisfy the increasing market demand.